scholarly journals The Nationwide Incidence of Retinal Vein Occlusion Following Dialysis due to End-Stage Renal Disease in Korea, 2004 through 2013

2021 ◽  
Vol 36 (30) ◽  
Author(s):  
Tae Hwan Moon ◽  
Joung-Ho Han ◽  
Minseok Kang ◽  
Ji Soo Kim ◽  
Jin Young Kim ◽  
...  
Medicine ◽  
2016 ◽  
Vol 95 (16) ◽  
pp. e3474 ◽  
Author(s):  
Yuh-Shin Chang ◽  
Shih-Feng Weng ◽  
Chun Chang ◽  
Jhi-Joung Wang ◽  
Sung-Huei Tseng ◽  
...  

Medicine ◽  
2015 ◽  
Vol 94 (47) ◽  
pp. e1960 ◽  
Author(s):  
San-Ni Chen ◽  
Te-Cheng Yang ◽  
Jian-Teng Lin ◽  
Ie-Bin Lian

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jangwook Lee ◽  
Hye Rim Choe ◽  
Sang Hyun Park ◽  
Kyung Do Han ◽  
Dong Ki Kim ◽  
...  

AbstractIt has been known that retinal vein occlusion (RVO) is associated with chronic kidney disease, especially end-stage renal disease (ESRD). However, little is known about the effect of kidney transplantation (KT) on RVO incidence in ESRD patients. This study aimed to compare the incidence of RVO in KT recipients (n = 10,498), matched ESRD patients (n = 10,498), and healthy controls (HCs, n = 10,498), using a long-term population-based cohort. The incidence of RVO was 2.74, 5.68, and 1.02 per 1000 patient-years, for the KT group, the ESRD group, and the HCs group, respectively. Adjusted hazard ratios for RVO development compared to the HCs group, were 1.53 and 3.21, in the KT group and the ESRD group, respectively. In the KT group, multivariable regression analysis indicated that an age over 50, a Charlson Comorbidity Index score over 4, and a history of desensitization therapy were associated with an increased risk of RVO. In summary, KT recipients have a lower risk for development of RVO than ESRD patients treated with dialysis. However, the risk is still higher compared to healthy people who have normal kidney functions.


2018 ◽  
Vol 20 (3) ◽  
pp. 250-259 ◽  
Author(s):  
Zaghloul Elsafy Gouda ◽  
Mahmoud Mohamed Emara ◽  
Hany Said Elbarbary ◽  
Mahmoud Abdel Aziz Koura ◽  
Ahmed Rabie Elarbagy

Introduction: Internal jugular vein occlusion often makes necessary the use of less desirable routes as external jugular, subclavian, and femoral vein approaches in addition to inferior vena cava approaches. This a prospective cross-sectional follow-up study of the alternative approaches for placement of cuffed hemodialysis catheters in end-stage renal disease patients with bilateral internal jugular vein occlusion from the interventional nephrology point of view. Method: The study was conducted on 134 end-stage renal disease patients who were referred for insertion of a challenging hemodialysis catheter due to bilateral internal jugular vein occlusion. Ultrasound Doppler guided catheter insertion was used as a routine practice in addition to fluoroscopy or post insertion X-ray to localize catheter tip position and exclude complications. Follow-up of patients was conducted until the end of the study or catheter removal. Findings: The most highly prevalent alternative approach is the trans-external iliac vein inferior vena cava approach (43.28%) followed by external jugular vein approach (14.93%), innominate vein approach (10.18%), internal jugular vein collaterals by interventional radiology (7.46%), femoral vein approach (7.46%), transhepatic approach (5.97%), subclavian vein approach (5.22%), and finally the retrograde femoral vein approach (1.49%). Discussion: End-stage renal disease patients maintained on regular hemodialysis who have bilateral internal jugular vein obstruction and non-functioning arteriovenous fistula/graft is a daily scenario in nephrology practice. Our study showed that there is a variety of approaches for the insertion of cuffed hemodialysis catheters other than occluded internal jugular veins. Interventional nephrologists have a major role in solving the problem of poor hemodialysis vascular access. These alternative approaches can conserve the anatomically limited number of percutaneous access sites in each patient.


Sign in / Sign up

Export Citation Format

Share Document